📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
100
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
41%
🔄 Reverse Split
45%
• 50-day avg $1.38 approaching $1 threshold
• Only 6 months cash — financial pressure
📉 Score Deterioration
40%
• Score rose 23 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 6 months remaining
💹 Market Data
Market Cap$35.52M
Shares Outstanding25.71M
Float494.1K
Cash$3.24M
Debt$3.34M
Short InterestN/A
🏛 Institutional Holdings
4 institutional holders · 948 shares
#1
UBS Group AG
87 shares
#2
Group One Trading, LLC
8 shares
📉 Short Interest
Short Interest211.6K
Days to Cover1.0
% of Float42.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
6-K
8K EVENT
Mar 20, 2026
EFFECT
EFFECT
Mar 18, 2026
6-K
8K EVENT
Mar 18, 2026
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for UCAR
📊 UCAR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 UCAR Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.